Cargando…
In silico SARS-CoV-2 vaccine development for Omicron strain using reverse vaccinology
BACKGROUND: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic began in 2019 but it remains as a serious threat today. To reduce and prevent spread of the virus, multiple vaccines have been developed. Despite the efforts in developing vaccines, Omicron strain of the virus has...
Autores principales: | Li, Vladimir, Lee, Chul, Yoo, DongAhn, Cho, Seoae, Kim, Heebal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166176/ https://www.ncbi.nlm.nih.gov/pubmed/35665465 http://dx.doi.org/10.1007/s13258-022-01255-8 |
Ejemplares similares
-
Reverse vaccinology approach towards the in-silico multiepitope vaccine development against SARS-CoV-2
por: Kumar, Vipul, et al.
Publicado: (2021) -
Establishment and evaluation of prediction model for multiple disease classification based on gut microbial data
por: Bang, Sohyun, et al.
Publicado: (2019) -
In-silico analysis of recombinant protein vaccines based on the spike protein of Indonesian SARS-CoV-2 through a reverse vaccinology approach
por: Febrianti, Riska A., et al.
Publicado: (2022) -
Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2
por: Tahir ul Qamar, Muhammad, et al.
Publicado: (2020) -
In silico analysis of epitope-based vaccine candidate against tuberculosis using reverse vaccinology
por: Bibi, Shaheen, et al.
Publicado: (2021)